View printer-friendly version << Back

Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017

GAITHERSBURG, Md., May 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2017 financial and operating results following the close of U.S. financial markets on Monday, May 8, 2017.

Conference call details are as follows:

Date:      Monday, May 8, 2017
Time:    4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:   (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:   15607801
Webcast:, “Investors”/ “Events” 

Conference call and webcast replay:

Dates:      Starting at 7:30 p.m. ET, May 8, 2017, until 7:30 p.m. ET, May 15, 2017 
Dial-in number:    (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:    15607801
Webcast:, “Investors”/ “Events”

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.


Investor Relations
Novavax, Inc.Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

Westwicke PartnersJohn

Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.

Primary Logo

Novavax, Inc.

This site uses cookies and similar technologies to provide you with our services, enhance the performance and functionality of our services, and analyze the use of our products and services. By clicking ‘Accept’ you are indicating your consent for us to place these cookies. For more information, please read our Privacy Policy or manage your cookie settings.